The role of exception points in outcomes of patients with fibrocystic liver-kidney disease: Implications for the National Liver Review Board
Liver Transpl
.
2024 May 1;30(5):555-558.
doi: 10.1097/LVT.0000000000000314.
Epub 2023 Dec 15.
Authors
Benjamin E Rosenthal
1
,
Peter L Abt
2
,
K Rajender Reddy
3
,
Therese Bittermann
3
4
Affiliations
1
Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
2
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
3
Department of Medicine, Division of Gastroenterology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
4
Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
PMID:
38100283
PMCID:
PMC11023753
DOI:
10.1097/LVT.0000000000000314
No abstract available
MeSH terms
Cysts* / surgery
Humans
Kidney Diseases* / surgery
Liver Diseases* / surgery
Liver Transplantation*
Treatment Outcome
Supplementary concepts
Polycystic liver disease
Grants and funding
K08 DK117013/DK/NIDDK NIH HHS/United States
R01 AG079911/AG/NIA NIH HHS/United States